Company · CIK 0001553643 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
RELMADA THERAPEUTICS, INC. · RLMD
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 PForm 4 → | Sep 11, 7:30 am EDT | Maged ShenoudaChief Financial Officer | 200,000 | $4.22 | $843,990 | 1,000,000 | +25.0% | |
| Sep 9, 2026 PForm 4 → | Sep 11, 7:30 am EDT | Sergio TraversaChief Executive Officer, Director | 200,000 | $4.14 | $828,000 | 1,500,000 | +15.4% | |
| Dec 11, 2018 PForm 4 → | Dec 11, 4:21 pm EST | Paul Edward KellyDirector | 5,000 | $1.21 | $6,065 | 388,483 | +1.30% | plan? |
| Oct 18, 2018 CForm 4 → | Oct 19, 1:02 pm EDT | Paul Edward KellyDirector | 223,483 | $0.72 | $160,908 | 383,483 | — | plan? |
| Oct 12, 2018 PForm 4 → | Oct 19, 1:02 pm EDT | Paul Edward KellyDirector | 150,000 | $0.90 | $135,000 | 160,000 | +1,500% | plan? late |
| Dec 31, 2015 PForm 4 → | Jan 5, 2016, 4:35 pm EST | Shreeram AgharkarDirector | 400 | $2.50 | $1,000 | 5,759 | +7.46% | plan? |
| Dec 16, 2015 PForm 4 → | Dec 17, 9:35 am EST | Shreeram AgharkarDirector | 1,100 | $3.43 | $3,775 | 5,359 | +25.8% | plan? |
| Dec 15, 2015 PForm 4 → | Dec 17, 9:38 am EST | Sandesh SethDirector | 9,500 | $3.19 | $30,313 | 123,258 | +8.35% | plan? |
| Dec 15, 2015 PForm 4 → | Dec 17, 9:37 am EST | Maged ShenoudaDirector | 3,000 | $2.99 | $8,958 | 5,000 | +150% | plan? |
| Dec 15, 2015 PForm 4 → | Dec 17, 9:36 am EST | Sergio TraversaChief Executive Officer, Director | 18,970 | $3.05 | $57,792 | 339,322 | +5.92% | plan? |
| Dec 14, 2015 PForm 4 → | Dec 16, 4:28 pm EST | Sandesh SethDirector | 10,500 | $2.93 | $30,728 | 113,758 | +10.2% | plan? |
| Dec 14, 2015 PForm 4 → | Dec 16, 4:27 pm EST | Paul Edward KellyDirector | 10,000 | $2.91 | $29,055 | 10,000 | — | plan? |
| Dec 14, 2015 PForm 4 → | Dec 16, 4:25 pm EST | Sergio TraversaChief Executive Officer, Director | 30 | $2.97 | $89 | 320,352 | +0.01% | plan? |
| Dec 14, 2015 PForm 4 → | Dec 16, 4:23 pm EST | Maged ShenoudaDirector | 2,000 | $2.89 | $5,780 | 2,000 | — | plan? |
| Dec 14, 2015 PForm 4 → | Dec 16, 4:22 pm EST | Charles J CasamentoDirector | 4,200 | $2.97 | $12,464 | 4,200 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 20, 2018 AForm 4 → | Dec 20, 4:57 pm EST | Ottavio V. VitoloChief Medical Officer | 400,000 | $1.15 | $460,000 | 400,000 | — | |
| Dec 20, 2018 AForm 4 → | Dec 20, 4:56 pm EST | Sergio TraversaChief Executive Officer, Director | 900,000 | $1.15 | $1,035,000 | 900,000 | — | |
| Dec 20, 2018 AForm 4 → | Dec 20, 4:55 pm EST | Maged ShenoudaDirector | 450,000 | $1.15 | $517,500 | 450,000 | — | |
| Dec 20, 2018 AForm 4 → | Dec 20, 4:54 pm EST | Paul Edward KellyDirector | 500,000 | $1.15 | $575,000 | 500,000 | — | |
| Dec 20, 2018 AForm 4 → | Dec 20, 4:53 pm EST | Charles J CasamentoDirector | 450,000 | $1.15 | $517,500 | 450,000 | — | |
| Oct 12, 2018 PForm 4 → | Oct 19, 1:02 pm EDT | Paul Edward KellyDirector | 97,500 | $1.50 | $146,250 | 97,500 | — | late |
| Oct 20, 2017 AForm 4 → | Oct 23, 4:40 pm EDT | Maged ShenoudaDirector | 425,000 | $0.81 | $344,250 | 425,000 | — | |
| Oct 20, 2017 AForm 4 → | Oct 23, 4:38 pm EDT | Paul Edward KellyDirector | 450,000 | $0.81 | $364,500 | 450,000 | — | |
| Oct 20, 2017 AForm 4 → | Oct 23, 4:36 pm EDT | Charles J CasamentoDirector | 425,000 | $0.81 | $344,250 | 425,000 | — | |
| Oct 19, 2017 AForm 4 → | Oct 23, 4:42 pm EDT | Sergio TraversaChief Executive Officer, Director | 850,000 | $0.81 | $688,500 | 850,000 | — | |
| Oct 4, 2017 PForm 4 → | Oct 6, 11:10 am EDT | Paul Edward KellyDirector | 300,000 | $1.00 | $300,000 | 100,000 | — | |
| Feb 23, 2015 AForm 4 → | Mar 5, 5:17 pm EST | Sergio TraversaChief Executive Officer, Director | 225,000 | $2.70 | $607,500 | 872,745 | — | late |
| Feb 23, 2015 AForm 4 → | Mar 5, 5:16 pm EST | Eliseo Oreste SalinasPresident and CSO | 225,000 | $2.70 | $607,500 | 250,944 | — | late |
| Feb 23, 2015 AForm 4 → | Mar 5, 5:15 pm EST | Douglas BeckChief Financial Officer | 25,000 | $2.70 | $67,500 | 104,437 | — | late |